Second Quarter Revenue 2017
-
Financial
MiMedx Announces That Its Second Quarter Revenue Exceeds The Guidance Range
MARIETTA, Ga., July 13, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics…
Read More »